Published in Rheumatol Int on April 03, 2011
Immunopathogenesis of osteoarthritis. Clin Immunol (2013) 1.29
Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS One (2012) 1.08
Proteomic analysis of synovial fluid: insight into the pathogenesis of knee osteoarthritis. Int Orthop (2013) 0.86
Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin. PLoS One (2012) 0.81
Mannose binding lectin and susceptibility to rheumatoid arthritis in Brazilian patients and their relatives. PLoS One (2014) 0.79
Association of MASP-2 levels and MASP2 gene polymorphisms with rheumatoid arthritis in patients and their relatives. PLoS One (2014) 0.77
Targeting mechanisms at sites of complement activation for imaging and therapy. Immunobiology (2015) 0.76
Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure. Liver Int (2014) 0.76
Development of a C3c-based ELISA method for the determination of anti-complementary potency of Bupleurum polysaccharides. Acta Pharm Sin B (2015) 0.75
Production of complement components by cells of the immune system. Clin Exp Immunol (2017) 0.75
CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression. Rheumatol Int (2013) 0.75
Deconstructing the Lectin Pathway in the Pathogenesis of Experimental Inflammatory Arthritis: Essential Role of the Lectin Ficolin B and Mannose-Binding Protein-Associated Serine Protease 2. J Immunol (2017) 0.75
Identification of potential serum biomarkers for rheumatoid arthritis by high-resolution quantitative proteomic analysis. Inflammation (2014) 0.75
Complement. First of two parts. N Engl J Med (2001) 11.16
Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat Med (1995) 3.38
Anti-C5 monoclonal antibody therapy prevents collagen-induced arthritis and ameliorates established disease. Proc Natl Acad Sci U S A (1995) 2.22
The transcriptional program of terminal granulocytic differentiation. Blood (2004) 1.80
Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun (2005) 1.64
Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods (2003) 1.54
Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol (2005) 1.49
Rheumatoid arthritis and the complement system. Ann Med (2007) 1.42
Characteristics and biological variations of M-ficolin, a pattern recognition molecule, in plasma. J Innate Immun (2009) 1.19
Synovial fluid levels of complement SC5b-9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum (1991) 1.09
Intra-articular hyaluronan is without clinical effect in knee osteoarthritis: a multicentre, randomised, placebo-controlled, double-blind study of 337 patients followed for 1 year. Ann Rheum Dis (2010) 1.02
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis (1989) 1.02
Complement in acute and chronic arthritides: assessment of C3c, C9, and protectin (CD59) in synovial membrane. Ann Rheum Dis (1996) 1.00
Differential role of the lectin pathway of complement activation in susceptibility to neonatal sepsis. Clin Infect Dis (2010) 0.98
Localization of antigen-antibody complexes in intraarticular collagenous tissues. Ann N Y Acad Sci (1975) 0.95
Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) (2007) 0.91
Biological variation in circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol (2007) 0.89
The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins. Scand J Rheumatol Suppl (2004) 0.89
Humoral pattern recognition molecules: mannan-binding lectin and ficolins. Adv Exp Med Biol (2009) 0.89
An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin Rheumatol (1987) 0.87
Impact of the complement cascade on posttraumatic cartilage inflammation and degradation. Histol Histopathol (2007) 0.86
Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls. J Rheumatol (2007) 0.84
Mannose-binding lectin gene polymorphisms are associated with disease activity and physical disability in untreated, anti-cyclic citrullinated peptide-positive patients with early rheumatoid arthritis. J Rheumatol (2009) 0.81
Assays for the mannan-binding lectin pathway. Curr Protoc Immunol (2004) 0.81
Superconducting interfaces between insulating oxides. Science (2007) 5.68
Electric field control of the LaAlO3/SrTiO3 interface ground state. Nature (2008) 4.53
The binding of anti-immunoglobulin antibodies to rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 3.88
A second serine protease associated with mannan-binding lectin that activates complement. Nature (1997) 3.64
Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein. J Immunol (1995) 3.30
Association of low levels of mannan-binding protein with a common defect of opsonisation. Lancet (1989) 3.12
Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today (1994) 2.81
Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet (2001) 2.64
Binding of the pentamer/hexamer forms of mannan-binding protein to zymosan activates the proenzyme C1r2C1s2 complex, of the classical pathway of complement, without involvement of C1q. J Immunol (1990) 2.55
Nanoscale control of an interfacial metal-insulator transition at room temperature. Nat Mater (2008) 2.47
A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogenetics (1994) 2.31
Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med (1990) 2.29
Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immunol Methods (2000) 2.22
The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clin Exp Immunol (1992) 1.98
MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity (2001) 1.84
Total immunoglobulin of rat thymocytes and thoracic duct lymphocytes. Eur J Immunol (1974) 1.84
Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods (1981) 1.83
Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins. Am J Physiol (1997) 1.81
Reconstitution of opsonizing activity by infusion of mannan-binding lectin (MBL) to MBL-deficient humans. Scand J Immunol (1998) 1.74
MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA). Ann Rheum Dis (2008) 1.71
Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes. Acta Derm Venereol (1993) 1.71
The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol (2001) 1.59
Pain thresholds and tenderness in neck and head following acute whiplash injury: a prospective study. Cephalalgia (2001) 1.59
Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med (2000) 1.56
Elevated levels of mannan-binding lectin [corrected] (MBL) and eosinophilia in patients of bronchial asthma with allergic rhinitis and allergic bronchopulmonary aspergillosis associate with a novel intronic polymorphism in MBL. Clin Exp Immunol (2006) 1.54
Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol (2006) 1.51
Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol (2003) 1.50
An assay for the mannan-binding lectin pathway of complement activation. J Immunol Methods (2001) 1.50
Graded experimental acute pancreatitis: monitoring of a renewed rabbit model focusing on the production of interleukin-8 (IL-8) and CD11b/CD18. Eur J Gastroenterol Hepatol (1999) 1.45
Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury. Scand J Immunol (2005) 1.44
Polyethylene particles stimulate monocyte chemotactic and activating factor production in synovial mononuclear cells in vivo. An immunohistochemical study in rabbits. Acta Orthop Scand (1995) 1.44
Structure and homology of human C1q receptor (collectin receptor). Immunology (1993) 1.37
Orbital reconstruction and the two-dimensional electron gas at the LaAlO3/SrTiO3 interface. Phys Rev Lett (2009) 1.37
Diallelic polymorphism may explain variations of the blood concentration of mannan-binding protein in Eskimos, but not in black Africans. Eur J Immunogenet (1992) 1.35
Proteolytic activities of two types of mannose-binding lectin-associated serine protease. J Immunol (2000) 1.34
Passage of undegraded dietary antigen into the blood of healthy adults. Quantification, estimation of size distribution, and relation of uptake to levels of specific antibodies. Scand J Immunol (1985) 1.34
Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease. Biochem J (1996) 1.30
Distinct pathways of mannan-binding lectin (MBL)- and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J Immunol (2000) 1.28
In vivo and in vitro antibacterial activity of conglutinin, a mammalian plasma lectin. Scand J Immunol (1990) 1.28
Detection and quantitation of immune complexes with a rapid polyethylene glycol precipitation complement consumption method (PEG-CC). Methods Enzymol (1981) 1.26
Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J Biol Chem (2001) 1.26
M-ficolin, an innate immune defence molecule, binds patterns of acetyl groups and activates complement. Scand J Immunol (2005) 1.22
Profiling the interface electron gas of LaAlO3/SrTiO3 heterostructures with hard x-ray photoelectron spectroscopy. Phys Rev Lett (2009) 1.21
Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS (1993) 1.21
Methotrexate compliance among patients with rheumatoid arthritis: the influence of disease activity, disease duration, and co-morbidity in a 10-year longitudinal study. Scand J Rheumatol (2010) 1.20
Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man. Biochem J (1989) 1.20
Interaction of C1q receptor with lung surfactant protein A. Eur J Immunol (1992) 1.18
Neutrophil deactivation by influenza A viruses: mechanisms of protection after viral opsonization with collectins and hemagglutination-inhibiting antibodies. Blood (1996) 1.16
Chronic tendinopathy tissue pathology, pain mechanisms, and etiology with a special focus on inflammation. Scand J Med Sci Sports (2008) 1.15
Magnetic resonance imaging of sacroiliitis in early seronegative spondylarthropathy. Abnormalities correlated to clinical and laboratory findings. Rheumatology (Oxford) (2003) 1.14
The T lymphocyte antigen receptor--paradigm lost. Nature (1982) 1.13
Rapid screening assay for mutagen sensitivity and DNA repair capacity in human peripheral blood lymphocytes. Mutagenesis (2001) 1.12
Oligosaccharide-mediated interactions of the envelope glycoprotein gp120 of HIV-1 that are independent of CD4 recognition. AIDS (1989) 1.11
Ultrasonography as a tool for diagnosis, guidance of local steroid injection and, together with pressure algometry, monitoring of the treatment of athletes with chronic jumper's knee and Achilles tendinitis: a randomized, double-blind, placebo-controlled study. Scand J Rheumatol (2004) 1.10
Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL. J Immunol (2001) 1.10
Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin Exp Immunol (1994) 1.09
Deficiency of mannan-binding lectin associated serine protease-2 due to missense polymorphisms. Genes Immun (2007) 1.08
Characterization and quantification of mouse mannan-binding lectins (MBL-A and MBL-C) and study of acute phase responses. Scand J Immunol (2001) 1.08
Gene frequency and partial protein characterization of an allelic variant of mannan binding protein associated with low serum concentrations. Clin Exp Immunol (1992) 1.08
Purification and characterization of two mannan-binding lectins from mouse serum. J Immunol (2000) 1.07
Studies on the carbohydrate-binding characteristics of human pulmonary surfactant-associated protein A and comparison with two other collectins: mannan-binding protein and conglutinin. Biochem J (1993) 1.07
The mannan-binding-lectin pathway of the innate immune response. Curr Opin Immunol (2001) 1.06
Passage of undegraded dietary antigen into the blood of healthy adults. Further characterization of the kinetics of uptake and the size distribution of the antigen. Scand J Immunol (1986) 1.06
A simple and reliable method for the drying of polyacrylamide slab gels. J Biochem Biophys Methods (1982) 1.06
Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera. Clin Exp Immunol (1983) 1.06
Role of the classical pathway of complement activation in experimentally induced polymicrobial peritonitis. Infect Immun (2001) 1.05
Two constituents of the initiation complex of the mannan-binding lectin activation pathway of complement are encoded by a single structural gene. J Immunol (1999) 1.05
Increased levels of mannan-binding lectin in type 1 diabetic patients with incipient and overt nephropathy. Diabetologia (2004) 1.05
Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. Int Arch Allergy Appl Immunol (1985) 1.05
Interaction of C1q and mannan-binding lectin (MBL) with C1r, C1s, MBL-associated serine proteases 1 and 2, and the MBL-associated protein MAp19. J Immunol (2000) 1.04
Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein. Mol Biochem Parasitol (1994) 1.04
Delineation of selective cyclic GMP-dependent protein kinase Ialpha substrate and inhibitor peptides based on combinatorial peptide libraries on paper. Pharmacol Ther (1999) 1.03
Binding of human collectins (SP-A and MBP) to influenza virus. Biochem J (1994) 1.03
GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab (2001) 1.03
Mannan-binding lectin modulates the response to HSV-2 infection. Clin Exp Immunol (2004) 1.02
Control of the classical and the MBL pathway of complement activation. Mol Immunol (2000) 1.02